Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1

Sponsor Class

OTHER 6INDUSTRY 3NIH 1

Study Type

Observational 3

Sponsor

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

Data Collection 2human papillomavirus vaccine, L1 type 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Abortion, Spontaneous × Clear all
NCT01653392 2024-03-15

BioThrax® (Anthrax) Vaccine in Pregnancy Registry

Emergent BioSolutions

Completed
98 enrolled

Congenital Abnormalities, Abortion, Spontaneous, Birth Weight, Eclampsia, Fetal Death, Hydatidiform Mole, Obstetric Labor, Premature, Pre-Eclampsia, Pregnancy Complications, Pregnancy, Ectopic, Diabetes, Gestational, Premature Birth, Stillbirth, Maternal Death

NCT01290393 2018-07-26

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

GlaxoSmithKline

Terminated
2 enrolled

Abortion, Spontaneous, Papillomavirus Infections

NCT01905462 2013-09-30

Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK

GlaxoSmithKline

Completed
1,046 enrolled

Abortion, Spontaneous, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡